Dr. Garg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
810 Bestgate Road
Suite 400
Annapolis, MD 21401Phone+1 410-897-6200Fax+1 410-266-7636- Is this information wrong?
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
- Johns Hopkins HospitalInstructor, Internal Medicine, 2006 - 2007
- University of Michigan Health SystemResidency, Internal Medicine, 2003 - 2006
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2003
- University of Michigan-Ann ArborBS, Microbiology, Phi Beta Kappa, Phi Kappa Phi, 1995 - 1999
Certifications & Licensure
- MD State Medical License 2006 - 2024
- TX State Medical License 2007 - 2011
- MI State Medical License 2003 - 2006
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow of the Year MD Anderson Cancer Center, 2010
- Chief Fellow for Education MD Anderson Cancer Center, 2008-2009
- Best Teacher Award MD Anderson Cancer Center, 2008-2009
- Join now to see all
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Publications & Presentations
PubMed
- 4 citationsDivergent RET- and BRAF-Mediated Resistance to Osimertinib in EGFR-Mutant NSCLC: A Case ReportMuneeb Rehman, Chul Kim, Joshua E. Reuss, Lesli A. Kiedrowski, Ravin J. Garg, Stephen V. Liu> ;JCO Precision Oncology. 2021 Jun 4
- 58 citationsOphthalmic manifestations of leukemia.Ravin J. Garg, Sunir J. Garg, Katherine E. Talcott> ;Current Opinion in Ophthalmology. 2016 Nov 1
- 21 citationsThe prognostic difference of monoallelic versus biallelic deletion of 13q in chronic lymphocytic leukemiaRavin J. Garg, William G. Wierda, Alessandra Ferrajoli, Lynne V. Abruzzo, Sherry Pierce, Susan Lerner, Michael J. Keating, Susan O'Brien> ;Cancer. 2012 Jul 15
- Join now to see all
Press Mentions
- In Proportion: Approaches for Displaying Patient-Reported Outcome Research Study Results as Percentages Responding to TreatmentNovember 29th, 2018
- Presenting Comparative Study PRO Results to Clinicians and Researchers: Beyond the Eye of the BeholderNovember 2nd, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: